BLZ-100

Known as: Chlorotoxin-Indocyanine Green Imaging Agent BLZ-100, Tumor Paint BLZ-100 
A tumor targeting imaging agent composed of the tumor-specific peptide chlorotoxin (CTX), a 36-amino acid neurotoxin found in the venom of the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
0120042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BLZ-100 is a single intravenous use, fluorescent imaging agent that labels tumor tissue to enable more complete and precise… (More)
Is this relevant?
2016
2016
IMPORTANCE Surgical cure of head and neck squamous cell carcinoma (HNSCC) remains hampered by inadequately resected tumors and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Nature inspires us to address the most contemporary scientific challenges. Advances in the drug delivery system at the nano/micro… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2015
2015
There is a need in surgical oncology for contrast agents that can enable real-time intraoperative visualization of solid tumors… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2014
2014
OBJECT The intraoperative clear delineation between brain tumor and normal tissue in real time is required to ensure near… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Chlorotoxin (CTX) is a scorpion-derived disulfide-rich peptide that targets malignant tumors by binding the cell surface matrix… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2011
2011
Bioconjugates composed of chlorotoxin and near-infrared fluorescent (NIRF) moieties are being advanced toward human clinical… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Chlorotoxin has been isolated from the venom of the scorpion Leiurus quinquestriatus and characterized as a 4.1kDa peptide… (More)
Is this relevant?